Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HYPRthis companyHyperfine, Inc.	$0.71	-2.28×	2.25×	6.8×	-1.67×	-270.1%	49.8%	-273.4%	-262.3%	-86.8%	-84.7%	-31.6%	0.01×	1.01×	0×	4.34×	0.0%	4	-6.81	1	C-
CNTBConnect Biopharma Holdings Limited	$0.75	-2.82×	3.74×	2,452.52×	-2.19×	-15.8%	100.0%	-90740.6%	-86687.5%	-132.2%	-135.7%	-32.9%	0.02×	0.69×	0×	3.74×	0.0%	2	-15.61	2	C+
IMAImageneBio Inc	$4.16	-0.72×	0.28×	46.85×	-0.28×	9.5%	-29.1%	-6056.4%	-5668.6%	-34.1%	-33.4%	-127.6%	0.08×	0.56×	0×	12.49×	0.0%	1	0.37	3	B
LUNGPulmonx Corporation	$2.81	-1.66×	1.66×	0.99×	-1.55×	-443.3%	74.2%	-59.3%	-59.7%	-99.8%	-48.5%	-36.6%	1.04×	0.28×	-17.01×	5.07×	0.0%	3	-5.79	2	C+
NSPRInspireMD, Inc.	$0.68	-2.34×	2.37×	14.56×	-2.59×	-939.0%	29.5%	-547.0%	-543.3%	-88.4%	-82.2%	-28.1%	0.06×	0.12×	0×	5.74×	0.0%	2	-11.16	2	C+
RCELAvita Medical Inc.	$18.08	-1.98×	-5.77×	1.34×	-3.2×	-278.6%	82.1%	-59.4%	-67.8%	291.8%	-113.0%	-34.3%	-2.77×	-0.87×	-8.5×	0.57×	0.0%	3	-9.92	2	C
Peer median	—	-1.98×	1.66×	14.56×	-2.19×	-278.6%	74.2%	-547.0%	-543.3%	-88.4%	-82.2%	-34.3%	0.06×	0.28×	0×	5.07×	0.0%	2	-9.92	2	—